Mankind Pharma Limited Appoints Anish Vanraj Bafna as Additional Independent Director
Mankind Pharma Limited has approved the appointment of Mr. Anish Vanraj Bafna as an Additional Non-Executive Independent Director, effective August 10, 2026, following the Company's Board meeting held on that day. The appointment is subject to subsequent approval by the members for a term spanning five consecutive years.The company noted that Mr. Bafna meets the requirements and criteria prescribed under relevant regulations concerning independent directorship.
Director Profile and Appointment Details
Mr. Anish Vanraj Bafna has been appointed based on his extensive experience in the healthcare and medical devices sector, boasting over 30 years of professional background. His profile includes significant involvement in managing global healthcare businesses and operations across multiple geographies.Prior to joining Mankind Pharma Limited, Mr. Bafna served as the Chief Executive Officer and Managing Director at Healthium Medtech Limited for more than eight years, where he was instrumental in driving the company's growth and transformation into a global entity. He currently serves as the Non-Executive Chairman of Healthium.
His previous career included roles at Baxter International, where he held positions such as Regional Head - Emerging Asia at Singapore and President - Japan. His international experience spans several countries including Vietnam, Indonesia, Malaysia, Singapore, Japan, and India. Mr. Bafna holds a Post Graduate Diploma in Management (PGDM) from IMDR, Pune, and a Bachelor's Degree in Science (Chemistry) from St. Xavier's, Ahmedabad.
A summary of the appointment details is provided below:
| Particulars | Details |
|---|---|
| Name | Mr. Anish Vanraj Bafna (DIN: 02925792) |
| Role | Additional Director (Non-Executive Independent Director) |
| Date of Appointment | August 10, 2026 |
| Term | 5 consecutive years, subject to members' approval |
| Independence Status | Not related to any Promoter, Director or Key Managerial Personnel and satisfies the criteria for Independence. |
Corporate Structure and Governance
The Board of Directors at Mankind Pharma Limited considered and approved the appointment of Mr. Anish Vanraj Bafna as an Additional Non-Executive Independent Director. The company is proceeding with the required procedures to seek the members' approval for this appointment via Postal Ballot Notice in due course.MANKIND Stock Price Movement
Shares of Mankind Pharma Limited slipped by 0.73% to settle at ₹2438 today, trailing gains from the previous close. The stock traded on heavy buying interest, with a total volume recorded at 230,964 shares during market hours.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.